Current view of the Epstein–Barr virus infection


DOI: https://dx.doi.org/10.18565/pharmateca.2019.10.27-34

A.S. Polyakova (1, 2), M.D. Bakradze (1), G.V. Dzhivanshiryan (1), V.K. Tatochenko (1)

1) National Medical Research Center for Children’s Health, Moscow, Russia; 2) Pirogov Russian National Research Medical University, Moscow, Russia

Epstein-Barr virus (EBV) is one of the most common human viruses that persists in more than 90–95% of the world’s population over 40 years old and is considered the main cause of infectious mononucleosis (IM). The extremely high prevalence of EBV infection among people and the high risk of developing related conditions raise the issue of further close study of the virus to one of the leading positions. The article provides information on the epidemiology, clinical picture, diagnosis and treatment of this disease.


For citations: Polyakova A.S., Bakradze M.D., Dzhivanshiryan G.V., Tatochenko V.K. Current view of the Epstein–Barr virus infection. Farmateka. 2019;26(10):27–34. (in Russian). DOI: https://dx.doi.org/10.18565/pharmateca.2019.10.27-34 


About the Autors


Corresponding author: Anastasiya S. Polyakova, PhD, Pediatrician at the Department of Diagnostics and Rehabilitation, National Medical Research Center for Children’s Health; Associate Professor at the Department of Faculty Pediatrics, Faculty of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia; e-mail: darmanyan@nczd.ru
Address: 2, build. 1, Lomonosovsky Prospect, Moscow 119991, Russian Federation


Similar Articles


Бионика Медиа